Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Epidemiological Study of a Prospective Cohort of Patients Aged 60 and Over Managed for Acute Myeloid Leukemia (AML) and Receiving Intensive Induction Therapy

NCT06891144 is registered in ClinicalTrials.gov with French Innovative Leukemia Organisation as lead sponsor.

NCT NCT06891144
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06891144 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Epidemiological Study of a Prospective Cohort of Patients Aged 60 and Over Managed for Acute Myeloid Leukemia (AML) and Receiving Intensive Induction Therapy
Lead sponsor
French Innovative Leukemia Organisation
Phase
Observational
Overall status
Recruiting
Start date
January 6, 2015
Completion date
January 6, 2031
Enrollment
1,000 (estimated)
Sites
27

Conditions

As the registry lists them; a condition with its own page is linked.

aml, adult